Applied Therapeutics, Inc. - ROE
APLT
Price:
$0.103
Market Cap:
$14.86M
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications. The company's primary drug candidate, AT-007, has successfully concluded Phase 1/2 studies for galactosemia in healthy adult volunteers and is presently in a pediatric clinical study for the same indication in children. Additionally, AT-007 is being investigated for its potential to address sorbitol dehydrogenase deficiency and phosphomannomutase enzyme-CDG. Another key compound, AT-001, is currently undergoing pivotal Phase III clinical trials. This therapy is being evaluated for its effic...[Read more]
Industry
Biotechnology
IPO Date
2019-05-14
Stock Exchange
NASDAQ
Ticker
APLT
PE Ratio
[-1.03]
ROE
[-65.63%]
Current Ratio
[0.96]
Dividend Yield
[0%]
Enterprise Value
[5.42M]
Dividend History
The ROE as of June 2026 (TTM) for Applied Therapeutics, Inc. (APLT) is -65.63%
According to Applied Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -65.63%. This represents a change of -108.00% compared to the average of 820.10% of the last 4 quarters.
Applied Therapeutics, Inc. (APLT) Historical ROE (quarterly & annually)
How has APLT ROE performed in the past?
The mean historical ROE of Applied Therapeutics, Inc. over the last ten years is -242.24%. The current -65.63% ROE has changed -72.91% with respect to the historical average. Over the past ten years (40 quarters), APLT's ROE was at its highest in in the September 2025 quarter at 3.39%. The ROE was at its lowest in in the September 2024 quarter at -1164.14%.
Average
-242.24%
Median
-127.13%
Minimum
-2031.72%
Maximum
698.49%
Applied Therapeutics, Inc. (APLT) ROE by Quarter and Year
Discovering the peaks and valleys of Applied Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.10%
Maximum Annual ROE = 698.49%
Minimum Annual Increase = -196.61%
Minimum Annual ROE = -2031.72%
| Year | ROE | Change |
|---|---|---|
| 2024 | -185.29% | -126.53% |
| 2023 | 698.49% | -134.38% |
| 2022 | -2031.72% | 1.10% |
| 2021 | -168.83% | 47.23% |
| 2020 | -114.67% | -17.85% |
| 2019 | -139.58% | 33.64% |
| 2018 | -104.44% | -196.61% |
Applied Therapeutics, Inc. (APLT) Average ROE
How has APLT ROE performed in the past?
The current ROE of Applied Therapeutics, Inc. (APLT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-506.17%
5-year avg
-360.40%
10-year avg
-242.24%
Applied Therapeutics, Inc. (APLT) ROE vs. Peers
How is APLT’s ROE compared to its peers?
Applied Therapeutics, Inc.’s ROE is greater than Molecular Partners AG (-66.19%), greater than Elicio Therapeutics, Inc. (-2748.16%), greater than Corbus Pharmaceuticals Holdings, Inc. (-70.89%), greater than Cardiff Oncology, Inc. (-95.50%), greater than PepGen Inc. (-59.89%), greater than Milestone Pharmaceuticals Inc. (-339.38%), greater than Rani Therapeutics Holdings, Inc. (-245.45%), greater than Nkarta, Inc. (-30.90%), greater than Cassava Sciences, Inc. (-99.85%), greater than Forte Biosciences, Inc. (-106.16%),
| Company | ROE | Market cap |
|---|---|---|
| -66.19% | $143.29M | |
| -2748.16% | $73.48M | |
| -70.89% | $103.54M | |
| -95.50% | $82.73M | |
| -59.89% | $123.81M | |
| -339.38% | $111.66M | |
| -245.45% | $51.11M | |
| -30.90% | $204.62M | |
| -99.85% | $63.77M | |
| -106.16% | $247.86M |
Build a custom stock screener for Applied Therapeutics, Inc. (APLT) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Applied Therapeutics, Inc. (APLT) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Applied Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Applied Therapeutics, Inc.'s ROE?
How is the ROE calculated for Applied Therapeutics, Inc. (APLT)?
What is the highest ROE for Applied Therapeutics, Inc. (APLT)?
What is the 3-year average ROE for Applied Therapeutics, Inc. (APLT)?
What is the 5-year average ROE for Applied Therapeutics, Inc. (APLT)?
How does the current ROE for Applied Therapeutics, Inc. (APLT) compare to its historical average?